Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MONTELUKAST for Nasal polyps: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where MONTELUKAST was used for Nasal polyps.

Most Reported Side Effects for MONTELUKAST

Side Effect Reports % Deaths Hosp.
Asthma 8,372 31.0% 208 3,766
Dyspnoea 6,354 23.6% 88 3,164
Wheezing 5,159 19.1% 52 2,588
Drug ineffective 3,539 13.1% 142 1,358
Cough 3,475 12.9% 25 1,633
Therapeutic product effect incomplete 3,352 12.4% 55 1,765
Anxiety 2,994 11.1% 72 666
Loss of personal independence in daily activities 2,736 10.1% 42 1,539
Sleep disorder due to a general medical condition 2,101 7.8% 46 1,156
Obstructive airways disorder 2,073 7.7% 45 1,209
Pneumonia 2,071 7.7% 78 890
Headache 2,047 7.6% 132 642
Depression 2,041 7.6% 37 419
Fatigue 1,959 7.3% 131 604
Drug hypersensitivity 1,792 6.6% 122 313

Other Indications for MONTELUKAST

Product used for unknown indication (11,960) Asthma (7,298) Hypersensitivity (852) Multiple allergies (518) Chronic spontaneous urticaria (416) Rhinitis allergic (344) Ill-defined disorder (222) Seasonal allergy (220) Cough (202) Urticaria (157)

Other Drugs Used for Nasal polyps

DUPILUMAB (21,908) MEPOLIZUMAB (757) FLUTICASONE (449) MOMETASONE FUROATE (236) OMALIZUMAB (168) BUDESONIDE (46) TRIAMCINOLONE ACETONIDE (26) PREDNISOLONE (23) BENRALIZUMAB (22) FLUTICASONE FUROATE (22)

Related Pages

MONTELUKAST Full Profile All Nasal polyps Drugs MONTELUKAST Demographics MONTELUKAST Timeline